EXIA:F:F-iShares DAX ESG UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 6.505

Change

+0.10 (+1.55)%

Market Cap

USD 0.07B

Volume

4.39K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.25%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.29%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.16 (+0.28%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.07 (+0.43%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.45 (+0.60%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

-0.77 (-0.70%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.23%)

USD 38.52B
0ZC:F Zscaler Inc

+3.40 (+1.90%)

USD 37.92B

ETFs Containing EXIA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.09% 60% D- 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.09% 59% D- 46% F
Trailing 12 Months  
Capital Gain 21.73% 76% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.73% 73% C 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.77% 65% D 63% D
Dividend Return 8.77% 63% D 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.51% 60% D- 87% B+
Risk Adjusted Return 76.17% 78% C+ 84% B
Market Capitalization 0.07B 27% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.